The Federal Trade Commission’s (FTCs) Bureau of Consumer Protection today announced the issuance of Health Products Compliance Guidance, the agency’s first revision of its business guidance in this area in nearly 25 years. One major revision is to extend the guidance covering dietary supplements to all health-related products.
The revised guide also reflects updates to other FTC guidance documents, including the guidance on endorsements and testimonials. Among other things, the new guide includes a much more detailed discussion of the amount and type of evidence needed to substantiate health-related claims, with more emphasis on the fact that the FTC, as a general rule, expects high quality randomized, controlled human clinical trials.
Related Posts
CMS Targets Deceptive Marketing and Improving Health Equity in Medicare Advantage (MA) Plans
In late 2022, the Centers for Medicare and Medicaid Services (CMS) released a proposed rule that takes aim at deceptive marketing in television commercials, online ads, and mailers related to Medicare Advantage plans. CMS proposes prohibiting ads that do not mention a specific plan name as well as ads that use words and imagery, such…
Academy Joins with Broad Provider Coalition to Advocate for Medicare Payment Reform
The Academy joined with a broad coalition of non-physician and physician providers to urge Congress to continue to work on long-term substantive payment reforms in Medicare. The Coalition letter provides that while Congress has taken action to address some of these fiscal challenges by mitigating some of the recent Medicare Physician Fee Schedule (MPFS) cuts,…
2023 Federal Omnibus Bill Includes Critical Healthcare Provisions
Legislative text of the end-of-year omnibus spending package was released in the early morning hours on December 20, 2022. This legislative package that will continue to fund the federal government is expected to pass both Houses and be signed into law before the start of the 118th Congress that begins in 2023. This legislative package:…